APS Management

Antiphospholipid syndrome, also known as ‘Hughes Syndrome’, is an autoimmune disease characterised by a set of clinical manifestations,…
Direct anticoagulants are currently used in patients with thromboembolism irrespective of the presence of antiphospholipid antibodies.

The direct oral anticoagulant Rivaroxaban was associated with more thrombosis than Warfarin, and should not be used in place of Warfarin for high-risk triple antibodies-positive APS patients.